[
    {
        "id": "osp-3424",
        "type": "article-journal",
        "title": "Comorbidity Patterns Among Outpatient COVID-19 Cases in Turkey",
        "author": [
            {
                "family": "Akgün",
                "given": "Hediye"
            },
            {
                "family": "Erdoğan",
                "given": "Tuğba Gürgen"
            },
            {
                "family": "Belibağlı",
                "given": "Mehmet Cenk"
            },
            {
                "family": "GÜNEŞ",
                "given": "GAMZE"
            },
            {
                "family": "Haberal",
                "given": "Ali"
            }
        ],
        "URL": "https://omanscience.com/en/articles/comorbidity-patterns-among-outpatient-covid-19-cases-in-turkey",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2025
                ]
            ]
        },
        "container-title": "Journal of the Oman Medical Association",
        "volume": "2",
        "issue": "1",
        "page": "2",
        "DOI": "10.3390/joma2010002",
        "publisher": "MDPI",
        "abstract": "Numerous factors contribute to COVID-19 symptoms, with individuals who have pre-existing health conditions at the highest risk for severe SARS-CoV-2 infection. This study investigated the socio-demographic and comorbidity profiles within a large Turkish population diagnosed with SARS-CoV-2, including 47,875 patients diagnosed between March 2020 and May 2022 across six hospitals in different Turkish cities. Patients with SARS-CoV-2 confirmed via laboratory tests and presenting symptoms were included. The data collected covered socio-demographic details, infection onset dates, COVID-19 symptoms, pre-existing health conditions, radiological findings, treatments, disease progression, and relevant variables. A total of 47,875 files were included in the analysis. The median age was 43.7 years, with 84.5% testing positive for PCR SARS-CoV-2, often correlating with severe symptoms. Notably, 11.8% of the participants exhibited mild symptoms, and approximately 12.8% had comorbidities, increasing to 17.6% among severe cases. Females with PCR-positive COVID-19 had a comorbidity rate of 13.8%, compared to 12.5% in males. Among the patients with comorbidities, those aged 70 and above had the highest rates, at 22.1% (n = 1103). The most prevalent comorbidity was hypertension, followed by diabetes and cardiovascular diseases. Severe cases had a significantly higher prevalence of comorbidities (58.4%) compared to non-severe cases (27.6%). We hope that the evaluation of our findings will contribute to the research and treatment processes of the COVID-19 outpatients."
    }
]